Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label long-term extension study of DiaPep277 in subjects completing study 1001
2013-002775-17Phase 3Terminated
- Sponsor
- Andromeda Biotech Ltd.
- Start
- Jul 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of diapep277 in diabetes mellitus type 1 (T1D), sponsored by Andromeda Biotech Ltd. Started Jul 2013; status: terminated.
02
Drugs
diapep277
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2013-002775-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002775-17.